Table 3.
Experimental model | Minimal effective dose | Predictive tests | References | ||
---|---|---|---|---|---|
Depression | Anxiety | ||||
(Octylseleno) xilofuranoside |
– | 0.001 | TST | – | Brod et al. (2016) |
(Fluorophenylselenyl)-2,5-diphenyl selenophene | – | 50 | FST | – | Gay et al. (2010) |
Corticosterone | 0.1a | FST, TST | LD, NSF | Gai et al. (2014b) | |
Partial sciatic nerve ligation | 1 | FST, TST | LD | Gai et al. (2014a) | |
1-Methyl-3-(phenylselanyl)-1H-indole | Streptozotocin (intracerebro ventricular) | 10 | FST, Splash | – | Bampi et al. (2020b) |
10a |
Social interact, TST Splash |
EPM | Bampi et al. (2019) | ||
(Chlorophenyl)selanyl]-1-methyl-1H-indole | Lipopolysaccharide | 1 |
TST Splash |
EPM MB |
Casaril et al. (2019b) |
Acute restrain stress | 1 |
TST Splash |
– | Casaril et al. (2019a) |
Selenides (mg kg−1) were intragastrically administered to Swiss mice 30 min before tests, excepting athat means repeated treatment (7 days),
FST forced swimming test, TST tail suspension test, LD light dark test, NSF novelty suppressed-feeding, EPM elevated plus maze, MB marble burying